Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
from NDTV Profit - Latest https://ift.tt/3hZqctF
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
from NDTV Profit - Latest https://ift.tt/3hZqctF
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
Comments
Post a Comment